SENSYNE HEALTH
LIVE

Serial Number

88282392

Owner

Sensyne Health Group Limited

Attorney

John Mueller

Filing Date

Jan 30, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SENSYNE HEALTH Trademark

Serial Number: 88282392 • Registration: 6139084

SENSYNE HEALTH is a trademark filed by Sensyne Health Group Limited on January 30, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Sensyne Health Group Limited (26 trademarks)

Schrödinger Building
Oxford, Oxfordshire OX44GE , GB

Entity Type: 99

Trademark Details

Filing Date

January 30, 2019

Registration Date

September 1, 2020

Published for Opposition

June 16, 2020

Goods & Services

Downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction, as well as environmental analysis and research; recorded artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction as well as environmental analysis and research; downloadable software, downloadable application software, downloadable interface software, downloadable software and downloadable computer software platform all for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, as well as environmental analysis and research and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction, as well as environmental analysis and research; recorded software, recorded application software, recorded interface software, recorded software and recorded computer software platform all for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction, as well as environmental analysis and research; downloadable data mining software for use in connection with pharmaceutical drug discovery, drug development, chemogenomics, toxicogenomics and drug response prediction; pre-recorded digital media, namely, hard drives, flash drives, compact discs, digital versatile discs and optical discs featuring data mining software for use in connection with pharmaceutical drug discovery, drug development, chemogenomics, toxicogenomics and drug response prediction; downloadable computer modelling and analysis software; pre-recorded digital media, namely, hard drives, flash drives, compact discs, digital versatile discs and optical discs, featuring downloadable computer modelling and analysis software; downloadable computer software for accessing, viewing and processing patient medical information for use in the healthcare field; pre-recorded digital media, namely, hard drives, flash drives, compact discs, digital versatile discs and optical discs featuring downloadable computer software for accessing, viewing and processing patient medical information for use in the healthcare field; development tools for computer and internet software, namely, downloadable computer software development tools; pre-recorded digital media, namely, hard drives, flash drives, compact discs, digital versatile discs and optical discs featuring development tools for computer and internet software, namely, computer software development tools; Downloadable computer software for use as an application programming interface; pre-recorded digital media, namely, hard drives, flash drives, compact discs, digital versatile discs and optical discs featuring computer software for use as an application programming interface; downloadable computer software applications for the development of digital virtual agents, predictive systems, cognitive process automation, visual computing applications, knowledge virtualisation, robotics and drones; pre-recorded digital media, namely, hard drives, flash drives, compact discs, digital versatile discs and optical discs, featuring computer software applications for the development of digital virtual agents, predictive systems, cognitive process automation, visual computing applications, knowledge virtualisation, robotics and drones; downloadable software applications enabling machine learning, natural language processing, genetic and deep learning algorithms, semantic ontologies, pattern recognition and knowledge modelling technologies; pre-recorded digital media, namely, hard drives, flash drives, compact discs, digital versatile discs and optical discs featuring software applications enabling machine learning, natural language processing, genetic and deep learning algorithms, semantic ontologies, pattern recognition and knowledge modelling technologies; downloadable computer applications that provide solutions for cognitive enhancement in respect of experience and productivity, accelerating processes, automation and autonomy; pre-recorded digital media, namely, hard drives, flash drives, compact discs, digital versatile discs and optical discs featuring computer applications that provide solutions for cognitive enhancement in respect of experience and productivity, accelerating processes, automation and autonomy

Pharmaceutical preparations and substances for medical purposes for use in the prevention and treatment of autoimmune and autoinflammatory diseases and disorders, bacterial infections, behavioral and mental disorders, blood diseases and disorders, chromosome disorders, congenital and genetic diseases and disorders, connective tissue diseases and disorders, ear, nose and throat diseases and disorders, female reproductive diseases and disorders, fungal infections, kidney and urinary diseases and disorders, male reproductive diseases and disorders, mouth diseases and disorders, musculoskeletal diseases and disorders, myelodysplastic syndromes, parasitic diseases, cardiovascular diseases and disorders, neurodegenerative diseases and disorders, oncological diseases and disorders and for the treatment or prevention of dermatological, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders and for the treatment or prevention of diabetes, coughs, colds, influenza, headaches and allergic reactions and infectious diseases and for use as anti-infectives, anti- inflammatories and vaccines

Business consulting services; analysis of data, namely, business data analysis; compilation of data, namely, business data; providing an online searchable database for use in the pharmaceuticals and healthcare fields, namely, providing a non- downloadable online searchable database for use in the pharmaceuticals and healthcare fields, namely, consumer product information; the provision of data as a service in the pharmaceuticals and healthcare fields, namely, business information in relation to pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction

Healthcare services; providing an online non-downloadable searchable database for use in the pharmaceuticals and healthcare fields, namely, medical information; the provision of data as a service in the pharmaceuticals and healthcare fields, namely, medical information in relation to pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction

Industrial analysis and research services, namely, industrial research in the pharmaceuticals and healthcare fields and the field of the environment; design and development of computer hardware and software; Software as a service (SAAS) services featuring artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction, as well as environmental analysis and research; data mining services; the provision of computer software as a service (SAAS) services featuring software for use in in connection with pharmaceutical drug discovery, drug development, chemogenomics, toxicogenomics and drug response prediction; the provision of data as a service in the pharmaceuticals and healthcare fields, namely, medical research information in relation to pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction; the provision of a network platform as a service, namely, platform as a service (PASS) featuring computer software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug develoment, phramaceutical market access, chemogenomics, toxicogenomics and drugs response prediction, as well as environmental analysis and research; the provision of a network or database management platform as a service, namely, platform as a service (PAAS) featuring computer network management software and database management software; hosting of digital content online; environmental research, namely, research in the field of environment protection; technical consultancy in the field of environmental protection; Development and testing of computing methods, algorithms and software; development and testing of computing methods, algorithms and software in a virtual space; scientific research and development and implementation of software and technology solutions which enable analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, and machine learning and research and design relating thereto and research relating to computer programming, and research and consultancy in the fields of artificial intelligence, machine learning, deep learning and reinforcement learning; scientific research services, namely, scientific and technological design, development and analysis of environments for reinforcement learning; providing information on computer technology and programming via a website; Website design and development for others, namely, development and creation of internet sites, and online databases, and internet portals; hosting an online website for others in the pharmaceuticals and healthcare fields, including diagnostic and therapeutic use, as well as environmental analysis and research; design and development of computer software and internet software; application service provider (ASP), namely, hosting of software platforms and computer software applications of others on the internet; application service provider, namely, hosting computer software applications for use by others; the provision of data and data management platforms though a computer network including cloud computing network, namely, providing temporary use of online non-downloadable data and data management software; providing computer network configuration services, computer network design for others, planning and development of electronic communications networks and wireless computer networks; the provision of computer software as a service (SAAS) services featuring computer software for accessing and viewing patient medical information for use in the healthcare field; leasing of a platform, network or sensors, namely, rental of computer hardware, computer peripherals and software; research and design relating to scientific and technological services, namely, scientific research in the pharmaceuticals and healthcare fields, including diagnostic and therapeutic use, as well as environmental analysis and research; development and implementation of software and hardware solutions in respect of digital virtual agents, predictive systems, cognitive process automation, visual computing applications, knowledge virtualisation, robotics and drones; development and implementation of software and hardware solutions which enable machine learning, pattern recognition and knowledge modelling technologies; development and implementation of software and hardware for self- calibration of sensors and detectors, automation and autonomy; consultancy in relation to the development and implementation of software and software based applications; information, advisory and consultancy services in respect of all of the aforesaid services; compilation of data, namely, data for pharmaceutical drug discovery, drug development, chemogenomics, toxicogenomics and drug response prediction; providing an online non-downloadable searchable database for use in the pharmaceuticals and healthcare fields, namely, medical research in relation to pharmaceutical drug discovery, drug development, chemogenomics, toxicogenomics and drug response prediction

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 1, 2025 REM1
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 5, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 5, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 5, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 5, 2025 REAP
REGISTERED-PRINCIPAL REGISTER
Sep 1, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 11, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
May 11, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 11, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 11, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 11, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2020 CRFA
ASSIGNED TO LIE
May 4, 2020 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 30, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 30, 2019 GNFN
FINAL REFUSAL E-MAILED
Oct 30, 2019 GNFR
FINAL REFUSAL WRITTEN
Oct 30, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 17, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 17, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 17, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 11, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2019 NWOS
NEW APPLICATION ENTERED
Feb 2, 2019 NWAP